Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma.

MLA

Huang, Chen, et al. “Targeting P38γ Synergistically Enhances Sorafenib-Induced Cytotoxicity in Hepatocellular Carcinoma.” Cell Biology & Toxicology, vol. 41, no. 1, Jan. 2025, pp. 1–18. EBSCOhost, https://doi.org/10.1007/s10565-024-09979-x.

APA

Huang, C., Zhang, C., Li, J., Duan, Y., Tang, Q., & Bi, F. (2025). Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma. Cell Biology & Toxicology, 41(1), 1–18. https://doi.org/10.1007/s10565-024-09979-x

Chicago

Huang, Chen, Chenliang Zhang, Jiajin Li, Yichun Duan, Qiulin Tang, and Feng Bi. 2025. “Targeting P38γ Synergistically Enhances Sorafenib-Induced Cytotoxicity in Hepatocellular Carcinoma.” Cell Biology & Toxicology 41 (1): 1–18. doi:10.1007/s10565-024-09979-x.